Company: MIRA
Filing Date: 2025-08-08
Form Type: DEFM14A
Source: 0001641172-25-022816
Chunk: 123

Company: MIRA PHARMACEUTICALS, INC.
Filing Date: 2025-08-08
Form: DEFM14A
Chunk 123
---
NY Common Stock were issued and outstanding, and Ten Million Shares of Preferred Stock, par value $0.001 per share (“ SKNY Preferred Stock”) of which none are outstanding as of the Measurement Date.. Between the Measurement Date and the date hereof, except as disclosed in Section ‎3.2.0of the SKNY Disclosure Schedule, no shares of SKNY Common Stock or SKNY Preferred Stock have been issued, and no rights to receive or subscribed for shares of SKNY Common Stock or SKNY Preferred Stock have been granted. All of the outstanding shares of SKNY Common Stock have been validly issued, fully paid, nonassessable and free of preemptive rights. Except as set forth above and as disclosed in Section ‎3.2.0of the SKNY Disclosure Schedule, there are no outstanding (i)shares, equity interests or other voting securities or Capital Stock of SKNY, (ii)securities of SKNY convertible into or exchangeable or exercisable for shares or other securities of SKNY, (iii)options, preemptive or other rights to acquire from SKNY, or obligations of SKNY to issue, any shares of stock, voting securities or securities convertible into or exchangeable or exercisable for shares or other securities of SKNY or (iv)equity equivalent interests in the ownership or earnings of SKNY or other similar rights (collectively “ SKNY Securities”). There are no outstanding rights or obligations of SKNY to repurchase, redeem or otherwise acquire any SKNY Securities. There are no voting agreements, voting trusts or other agreements or understandings to which SKNY is a party or by which SKNY is bound relating to the voting or registration of any shares of Capital Stock of SKNY.

3.2.1 Except as disclosed in Section ‎3.2.1of the SKNY Disclosure Schedule, there are no outstanding SKNY Securities that are convertible into or exchangeable or exercisable for, options or other rights to acquire from SKNY, any Capital Stock or other ownership interests in or any other securities of entity, and there exists no other contract, understanding, arrangement or obligation (whether or not contingent) providing for the issuance or sale, directly or indirectly, of any such Capital Stock. There are no outstanding contractual obligations of SKNY to repurchase, redeem or otherwise acquire any outstanding shares of Capital Stock or other ownership interests in any entity.

3.3 Authority Relative to This Agreement; Recommendation.

3.3.0 SKNY has all necessary corporate or similar power and authority